Thus, an aptamer-targeted nanosystem that enables the synergistic effect of siRNA, which directly knocks down the expression of PD-L1 on tumor cells, with a potent chemotherapeutic drug might be a viable way to eradicate TNBC cells. This evidence concerns the gene CD274 and neoplasm.